CINDY HASLAM: Open Payments
NPI 1710401229 · LOS ANGELES, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$559 in 16 payments from 8 companies in 2025. Trend: 2023 $235 · 2024 $535 · 2025 $559
Food & beverage: $559
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 6 | $211 |
| Novo Nordisk Inc | 1 | $121 |
| Exact Sciences Corporation | 3 | $85 |
| Merck Sharp & Dohme LLC | 2 | $45 |
| MERZ NORTH AMERICA, INC. | 1 | $32 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $25 |
| SANOFI PASTEUR INC. | 1 | $23 |
| Kowa Pharmaceuticals America, Inc. | 1 | $17 |
Products named: AREXVY, Ozempic, Cologuard Collection Kit, TRELEGY ELLIPTA, ROTATEQ, SHINGRIX, The Cologuard Plus Collection Kit, Kerendia.
Industry payments across CA — which companies pay providers there.
